How Much will the Plasma Fractionation Market be Worth in the Future

Allied Market Research has recently published a report titled "Plasma Fractionation Market by Product (Albumin, Immunoglobulins, and Coagulation Factor VIII), Application (Neurology, Hematology, Immunology, Critical Care, and Others), and End User (Hospitals and Research Laboratories): Global Opportunity Analysis and Industry Forecast, 2018-2028." According to the report, the global plasma fractionation market was valued at $16.82 billion in 2018 and is projected to reach $30.53 billion by 2028, growing at a CAGR of 6.1% from 2019 to 2028.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/943

Key Drivers, Restraints, and Opportunities:

The growth of the global plasma fractionation market is primarily driven by factors such as the increase in the geriatric population, the prevalence of rare diseases, and the rising usage of immunoglobulins in various medical fields. However, the high cost associated with plasma-derived products acts as a restraint on market growth. Nonetheless, there are ample growth opportunities in emerging countries.

Segment Analysis:

The immunoglobulins segment accounted for more than two-thirds of the total market share in 2018 and is expected to maintain its lead position throughout the forecast period. It is projected to register the largest CAGR of 6.7% from 2019 to 2028, driven by the increased recognition and treatment of immune deficiencies and the rising usage of high-dose IgG products in treating autoimmune neurologic diseases.

The neurology segment held the highest market share in 2018 and is estimated to maintain its leadership position in terms of revenue during the forecast period. It is expected to grow at the highest rate, with a CAGR of 6.8% from 2019 to 2028, attributed to the increased awareness related to the diagnosis and treatment of neurological disorders.

Regional Analysis:

China (including Taiwan) contributed to the highest market share in terms of revenue in 2018 and is expected to maintain its dominance throughout the forecast period. The country is projected to witness the largest CAGR of 9.2% from 2019 to 2026, driven by a significant patient base for disorders like hemophilia and Von Willebrand disease, coupled with rising awareness related to blood donations.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/943

Leading Market Players:

Grifols SA
Baxter International Inc.
CSL LTD.
Bio Product Laboratory
Octapharma AG
Sanquin
Laboratoire Francais Du Fractionnement Et Des
Kedrion
Biotest
Takeda Pharmaceuticals

Pre-Book Now with Discount:

Implantable Insulin Pump Market https://www.alliedmarketresearch.com/implantable-insulin-pump-market

Veterinary Medicine Market https://www.alliedmarketresearch.com/veterinary-medicine-market

Medical Device Packaging Market https://www.alliedmarketresearch.com/medical-device-packaging-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.